# FDA Inspection 1035425 - OneBlood, Inc. - November 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/07d1a044-e7e1-458f-9ca2-8276e48461c1
Source feed: FDA_Inspections

> FDA Inspection 1035425 for OneBlood, Inc. on November 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035425
- Company Name: OneBlood, Inc.
- Inspection Date: 2017-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1205867 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/oneblood-inc/2204bc0c-e2c5-415a-9201-669a967b2a23)
- [FDA Inspection 1155122 - 2021-09-14](https://www.keypedia.com/records/fda_inspections/oneblood-inc/659bf717-6481-42e5-84be-7e3a6a3fd307)
- [FDA Inspection 1155122 - 2021-09-14](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6d75f3e6-2f01-4264-a3cf-0c0e06cf42f2)
- [FDA Inspection 963704 - 2016-02-24](https://www.keypedia.com/records/fda_inspections/oneblood-inc/c14ca0ae-c16b-45e4-a1cd-dfcd4a1e18cf)
- [FDA Inspection 895099 - 2014-09-12](https://www.keypedia.com/records/fda_inspections/oneblood-inc/498485c1-277e-4f96-8b45-19b9f1a2121c)

Company: https://www.keypedia.com/companies/oneblood-inc/1a711da1-56ac-4f03-afde-b34be0cf1280

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d